Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma.
Authors
Plummer, RLorigan, Paul C
Brown, E
Zaucha, R
Moiseyenko, V
Demidov, L
Soriano, V
Chmielowska, E
Andrés, R
Kudryavtseva, G
Kahatt, C
Szyldergemajn, S
Extremera, S
de Miguel, B
Cullell-Young, M
Calvert, H
Affiliation
Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.Issue Date
2013-09-17
Metadata
Show full item recordAbstract
This phase I-II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced melanoma.Citation
Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma. 2013, 109 (6):1451-9 Br J CancerJournal
British Journal of CancerDOI
10.1038/bjc.2013.477PubMed ID
23989947Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2013.477